Mather Group, Llc. Edwards Lifesciences Corp Transaction History

Mather Group, Llc.

$9.81 Billion
Q3 2025

A detailed history of Mather Group, Llc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Mather Group, Llc. holds 4,992 shares of EW stock, worth $430,809. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,992

Previous 4,988 0.08%

Holding current value

$430,809

Previous $390,000 0.51%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 20, 2025	BUY	$73.75 - $81.83 $295 - $327	4 Added 0.08%	4,992 $388,000
Q2 2025 Jul 15, 2025	BUY	$67.07 - $78.22 $56,741 - $66,174	846 Added 20.42%	4,988 $390,000
Q1 2025 Apr 25, 2025	BUY	$67.95 - $76.19 $30,577 - $34,285	450 Added 12.19%	4,142 $300,000
Q4 2024 Jan 24, 2025	BUY	$64.54 - $75.92 $14,908 - $17,537	231 Added 6.67%	3,692 $273,000
Q3 2024 Oct 07, 2024	SELL	$59.7 - $93.78 $96,057 - $150,892	-1,609 Reduced 31.74%	3,461 $228,000

Q2 2024 Jul 08, 2024	BUY	$84.3 - $94.31 $152,667 - $170,795	1,811 Added 55.57%	5,070 $468,000
Q1 2024 Apr 08, 2024	SELL	$72.54 - $95.56 $128,323 - $169,045	-1,769 Reduced 35.18%	3,259 $311,000
Q4 2023 Feb 05, 2024	SELL	$61.71 - $77.76 $24,375 - $30,715	-395 Reduced 7.28%	5,028 $383,000
Q3 2023 Nov 13, 2023	BUY	$69.28 - $93.38 $25,910 - $34,924	374 Added 7.41%	5,423 $375,000
Q2 2023 Aug 08, 2023	BUY	$81.41 - $94.33 $411,039 - $476,272	5,049 New	5,049 $476,000
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $400,730 - $521,965	4,865 New	4,865 $402,000
Q2 2022 Aug 16, 2022	SELL	$86.5 - $128.27 $621,243 - $921,235	-7,182 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$101.96 - $128.34 $732,276 - $921,737	7,182 New	7,182 $846,000

Others Institutions Holding EW

# of Institutions

1,460

Shares Held

468M

Call Options Held

3.46M

Put Options Held

4.07M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $53.4B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mather Group, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Mather Group, Llc. with notifications on news.

Account